Hiratsuka, Japan

Yongzhe Yan

This inventor holds 2 USPTO granted patents. Top assignee: Fuji Photo Film Company, Limited. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yongzhe Yan. Retrieved from https://idiyas.com/inventor/yongzhe-yan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Yongzhe Yan: Pioneering Benzimidazole Compounds

Introduction: Yongzhe Yan, an accomplished inventor based in Hiratsuka, Japan, has made significant contributions to the field of pharmaceuticals with his innovative research on benzimidazole compounds. With a total of two patents to his name, Yan's work is paving the way for potential advancements in drug formulation and development.

Latest Patents: Some of Yan's most recent inventions include "Benzimidazole compounds and drugs containing the same." These novel compounds hold promise for various therapeutic applications, showcasing Yan's expertise and dedication to enhancing medicinal chemistry.

Career Highlights: Currently, Yongzhe Yan is associated with Fuji Photo Film Company, Limited, a respected name in the industry. His role at the company emphasizes his commitment to innovation and the application of his research in developing new pharmaceuticals.

Collaborations: Throughout his career, Yongzhe Yan has collaborated with esteemed colleagues such as Kozo Aoki and Kazuhiro Aikawa. These professional partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking inventions.

Conclusion: Yongzhe Yan's contributions to the field of pharmaceutical innovation through his development of benzimidazole compounds are noteworthy. His work not only highlights the importance of collaboration and research but also has the potential to improve drug development for various medical conditions. As he continues to innovate, the scientific community eagerly anticipates his future contributions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…